TY - JOUR
T1 - The Systemic Effects of Exercise on the Systemic Effects of Alzheimer’s Disease
AU - Aczel, Dora
AU - Gyorgy, Bernadett
AU - Bakonyi, Peter
AU - Bukhari, Rehan
AU - Pinho, Ricardo
AU - Boldogh, Istvan
AU - Yaodong, Gu
AU - Radak, Zsolt
N1 - Funding Information:
Funding: This research was funded by Innovation and Technology Ministry, Hungary, grant number National Excellence Program (126823), and Scientific Excellence Program TKP2020-NKA-17 and TKP2021-EGA-37, at the University of Physical Education, awarded to Z.R.
Publisher Copyright:
© 2022 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2022/5
Y1 - 2022/5
N2 - Alzheimer’s disease (AD) is a progressive degenerative disorder and a leading cause of dementia in the elderly. The etiology of AD is multifactorial, including an increased oxidative state, deposition of amyloid plaques, and neurofibrillary tangles of the tau protein. The formation of amyloid plaques is considered one of the first signs of the illness, but only in the central nervous system (CNS). Interestingly, results indicate that AD is not just localized in the brain but is also found in organs distant from the brain, such as the cardiovascular system, gut microbiome, liver, testes, and kidney. These observations make AD a complex systemic disorder. Still, no effective medications have been found, but regular physical activity has been considered to have a positive impact on this challenging disease. While several articles have been published on the benefits of physical activity on AD development in the CNS, its peripheral effects have not been discussed in detail. The provocative question arising is the following: is it possible that the beneficial effects of regular exercise on AD are due to the systemic impact of training, rather than just the effects of exercise on the brain? If so, does this mean that the level of fitness of these peripheral organs can directly or indirectly influence the incidence or progress of AD? Therefore, the present paper aims to summarize the systemic effects of both regular exercise and AD and point out how common exercise-induced adaptation via peripheral organs can decrease the incidence of AD or attenuate the progress of AD.
AB - Alzheimer’s disease (AD) is a progressive degenerative disorder and a leading cause of dementia in the elderly. The etiology of AD is multifactorial, including an increased oxidative state, deposition of amyloid plaques, and neurofibrillary tangles of the tau protein. The formation of amyloid plaques is considered one of the first signs of the illness, but only in the central nervous system (CNS). Interestingly, results indicate that AD is not just localized in the brain but is also found in organs distant from the brain, such as the cardiovascular system, gut microbiome, liver, testes, and kidney. These observations make AD a complex systemic disorder. Still, no effective medications have been found, but regular physical activity has been considered to have a positive impact on this challenging disease. While several articles have been published on the benefits of physical activity on AD development in the CNS, its peripheral effects have not been discussed in detail. The provocative question arising is the following: is it possible that the beneficial effects of regular exercise on AD are due to the systemic impact of training, rather than just the effects of exercise on the brain? If so, does this mean that the level of fitness of these peripheral organs can directly or indirectly influence the incidence or progress of AD? Therefore, the present paper aims to summarize the systemic effects of both regular exercise and AD and point out how common exercise-induced adaptation via peripheral organs can decrease the incidence of AD or attenuate the progress of AD.
KW - Alzheimer’s disease
KW - amyloid-β
KW - exercise
KW - free radicals
KW - metabolism
KW - peripheral organs
UR - http://www.scopus.com/inward/record.url?scp=85138413165&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85138413165&partnerID=8YFLogxK
U2 - 10.3390/ANTIOX11051028
DO - 10.3390/ANTIOX11051028
M3 - Review article
AN - SCOPUS:85138413165
SN - 2076-3921
VL - 11
JO - Antioxidants
JF - Antioxidants
IS - 5
M1 - 1028
ER -